426 related articles for article (PubMed ID: 31706979)
1. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway.
Zhang Z; Wang S; Zhou S; Yan X; Wang Y; Chen J; Mellen N; Kong M; Gu J; Tan Y; Zheng Y; Cai L
J Mol Cell Cardiol; 2014 Dec; 77():42-52. PubMed ID: 25268649
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.
Gu J; Cheng Y; Wu H; Kong L; Wang S; Xu Z; Zhang Z; Tan Y; Keller BB; Zhou H; Wang Y; Xu Z; Cai L
Diabetes; 2017 Feb; 66(2):529-542. PubMed ID: 27903744
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway.
Xin Y; Bai Y; Jiang X; Zhou S; Wang Y; Wintergerst KA; Cui T; Ji H; Tan Y; Cai L
Redox Biol; 2018 May; 15():405-417. PubMed ID: 29353218
[TBL] [Abstract][Full Text] [Related]
7. 4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress.
Ma T; Zheng Z; Guo H; Lian X; Rane MJ; Cai L; Kim KS; Kim KT; Zhang Z; Bi L
Toxicol Appl Pharmacol; 2019 May; 370():93-105. PubMed ID: 30876865
[TBL] [Abstract][Full Text] [Related]
8. Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice.
Wang J; Wang S; Wang W; Chen J; Zhang Z; Zheng Q; Liu Q; Cai L
J Cell Mol Med; 2019 Sep; 23(9):6319-6330. PubMed ID: 31270951
[TBL] [Abstract][Full Text] [Related]
9. Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation.
Bai Y; Cui W; Xin Y; Miao X; Barati MT; Zhang C; Chen Q; Tan Y; Cui T; Zheng Y; Cai L
J Mol Cell Cardiol; 2013 Apr; 57():82-95. PubMed ID: 23353773
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice.
Zhou S; Wang J; Yin X; Xin Y; Zhang Z; Cui T; Cai J; Zheng Y; Liu Q; Cai L
Redox Biol; 2018 Oct; 19():11-21. PubMed ID: 30096613
[TBL] [Abstract][Full Text] [Related]
11. 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.
Zheng Z; Ma T; Guo H; Kim KS; Kim KT; Bi L; Zhang Z; Cai L
J Cell Mol Med; 2019 Aug; 23(8):5771-5781. PubMed ID: 31199069
[TBL] [Abstract][Full Text] [Related]
12. Broccoli sprout extract prevents diabetic cardiomyopathy via Nrf2 activation in db/db T2DM mice.
Xu Z; Wang S; Ji H; Zhang Z; Chen J; Tan Y; Wintergerst K; Zheng Y; Sun J; Cai L
Sci Rep; 2016 Jul; 6():30252. PubMed ID: 27457280
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane alleviates high fat diet-induced insulin resistance via AMPK/Nrf2/GPx4 axis.
Zhang Y; Wu Q; Liu J; Zhang Z; Ma X; Zhang Y; Zhu J; Thring RW; Wu M; Gao Y; Tong H
Biomed Pharmacother; 2022 Aug; 152():113273. PubMed ID: 35709656
[TBL] [Abstract][Full Text] [Related]
14. Sinapic acid ameliorates cardiac dysfunction and cardiomyopathy by modulating NF-κB and Nrf2/HO-1 signaling pathways in streptozocin induced diabetic rats.
Raish M; Ahmad A; Bin Jardan YA; Shahid M; Alkharfy KM; Ahad A; Ansari MA; Abdelrahman IA; Al-Jenoobi FI
Biomed Pharmacother; 2022 Jan; 145():112412. PubMed ID: 34768051
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2.
Wu H; Kong L; Cheng Y; Zhang Z; Wang Y; Luo M; Tan Y; Chen X; Miao L; Cai L
Free Radic Biol Med; 2015 Dec; 89():431-42. PubMed ID: 26415026
[TBL] [Abstract][Full Text] [Related]
16. Protection by sulforaphane from type 1 diabetes-induced testicular apoptosis is associated with the up-regulation of Nrf2 expression and function.
Jiang X; Bai Y; Zhang Z; Xin Y; Cai L
Toxicol Appl Pharmacol; 2014 Sep; 279(2):198-210. PubMed ID: 24967692
[TBL] [Abstract][Full Text] [Related]
17. Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects.
Li R; Liu Y; Shan YG; Gao L; Wang F; Qiu CG
Oxid Med Cell Longev; 2019; 2019():3206542. PubMed ID: 31354905
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart.
Yang G; Zhang Q; Dong C; Hou G; Li J; Jiang X; Xin Y
J Cell Physiol; 2024 Feb; 239(2):e31149. PubMed ID: 38308838
[TBL] [Abstract][Full Text] [Related]
19. Activation of Nrf2 by Sulforaphane Inhibits High Glucose-Induced Progression of Pancreatic Cancer via AMPK Dependent Signaling.
Chen X; Jiang Z; Zhou C; Chen K; Li X; Wang Z; Wu Z; Ma J; Ma Q; Duan W
Cell Physiol Biochem; 2018; 50(3):1201-1215. PubMed ID: 30355942
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane reduction of testicular apoptotic cell death in diabetic mice is associated with the upregulation of Nrf2 expression and function.
Wang Y; Zhang Z; Guo W; Sun W; Miao X; Wu H; Cong X; Wintergerst KA; Kong X; Cai L
Am J Physiol Endocrinol Metab; 2014 Jul; 307(1):E14-23. PubMed ID: 24801392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
